Literature DB >> 30566231

Piloting and implementation of quality assessment and quality control procedures in RBC-Omics: a large multi-center study of red blood cell hemolysis during storage.

Mars Stone1,2, Sheila M Keating1,2, Tamir Kanias3,4, Marion C Lanteri1,2, Mila Lebedeva1, Derek Sinchar3, Dylan Hampton1, Adam Jakub3, Val Rychka3, Greg Brewer3, Sonia Bakkour1, Nelly Gefter1, Karla Murcia1, Grier P Page5, Stacy Endres-Dighe6, Walter Bialkowski7, Xiaoyun Fu8, Jim Zimring8, Thomas J Raife9, Steve Kleinman10, Mark T Gladwin3,4, Michael P Busch1,2.   

Abstract

BACKGROUND: The major aims of the RBC-Omics study were to evaluate the genomic and metabolomic determinants of spontaneous and stress-induced hemolysis during RBC storage. This study was unique in scale and design to allow evaluation of RBC donations from a sufficient number of donors across the spectrum of race, ethnicity, sex, and donation intensity. Study procedures were carefully piloted, optimized, and controlled to enable high-quality data collection.
METHODS: The enrollment goal of 14,000 RBC donors across four centers, with characterization of RBC hemolysis across two testing laboratories, required rigorous piloting and optimization and establishment of a quality assurance (QA) and quality control (QC) program. Optimization of WBC elution from leukoreduction (LR) filters, development and validation of small-volume transfer bags, impact of manufacturing and sample-handling procedures on hemolysis parameters, and testing consistency across laboratories and technicians and over time were part of this quality assurance/quality control program.
RESULTS: LR filter elution procedures were optimized for obtaining DNA for analysis. Significant differences between standard and pediatric storage bags led to use of an alternative LR-RBC transfer bag. The impact of sample preparation and freezing methods on metabolomics analyses was evaluated. Proficiency testing monitored and documented testing consistency across laboratories and technicians.
CONCLUSION: Piloting and optimization, and establishment of a robust quality assurance/quality control program documented process consistency throughout the study and was essential in executing this large-scale multicenter study. This program supports the validity of the RBC-Omics study results and a sample repository that can be used in future studies.
© 2018 AABB.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30566231     DOI: 10.1111/trf.15099

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  Intradonor reproducibility and changes in hemolytic variables during red blood cell storage: results of recall phase of the REDS-III RBC-Omics study.

Authors:  Marion C Lanteri; Tamir Kanias; Sheila Keating; Mars Stone; Yuelong Guo; Grier P Page; Donald J Brambilla; Stacy M Endres-Dighe; Alan E Mast; Walter Bialkowski; Pam D'Andrea; Ritchard G Cable; Bryan R Spencer; Darrell J Triulzi; Edward L Murphy; Steven Kleinman; Mark T Gladwin; Michael P Busch
Journal:  Transfusion       Date:  2018-11-08       Impact factor: 3.157

2.  Diversity in a blood bag: application of omics technologies to inform precision Transfusion Medicine.

Authors:  Tamir Kanias; Michael P Busch
Journal:  Blood Transfus       Date:  2019-06-05       Impact factor: 3.443

Review 3.  Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage?

Authors:  Angelo D'Alessandro; Kirk C Hansen; Elan Z Eisenmesser; James C Zimring
Journal:  Blood Transfus       Date:  2019-06-06       Impact factor: 3.443

4.  Nicotine exposure increases markers of oxidant stress in stored red blood cells from healthy donor volunteers.

Authors:  Davide Stefanoni; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Travis Nemkov; Grier P Page; Larry Dumont; Nareg Roubinian; Mars Stone; Steve Kleinman; Michael Busch; James C Zimring; Angelo D'Alessandro
Journal:  Transfusion       Date:  2020-05-08       Impact factor: 3.157

5.  Ethyl glucuronide, a marker of alcohol consumption, correlates with metabolic markers of oxidant stress but not with hemolysis in stored red blood cells from healthy blood donors.

Authors:  Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch
Journal:  Transfusion       Date:  2020-05-08       Impact factor: 3.157

6.  Stored RBC metabolism as a function of caffeine levels.

Authors:  Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Grier P Page; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch
Journal:  Transfusion       Date:  2020-05-11       Impact factor: 3.157

7.  Sex hormone intake in female blood donors: impact on haemolysis during cold storage and regulation of erythrocyte calcium influx by progesterone.

Authors:  Fang Fang; Kelsey Hazegh; Derek Sinchar; Yuelong Guo; Grier P Page; Alan E Mast; Steve Kleinman; Michael P Busch; Tamir Kanias
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

8.  Impact of taurine on red blood cell metabolism and implications for blood storage.

Authors:  Lorenzo Bertolone; Micaela Kalani Roy; Ariel M Hay; Evan J Morrison; Davide Stefanoni; Xiaoyun Fu; Tamir Kanias; Steve Kleinman; Larry J Dumont; Mars Stone; Travis Nemkov; Michael P Busch; James C Zimring; Angelo D'Alessandro
Journal:  Transfusion       Date:  2020-04-27       Impact factor: 3.157

Review 9.  The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction.

Authors:  Abdelnaby Khalyfa; David Sanz-Rubio
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  Blood donor obesity is associated with changes in red blood cell metabolism and susceptibility to hemolysis in cold storage and in response to osmotic and oxidative stress.

Authors:  Kelsey Hazegh; Fang Fang; Marjorie D Bravo; Johnson Q Tran; Marcus O Muench; Rachael P Jackman; Nareg Roubinian; Lorenzo Bertolone; Angelo DʼAlessandro; Larry Dumont; Grier P Page; Tamir Kanias
Journal:  Transfusion       Date:  2020-11-04       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.